BI-1347 |CAS:2163056-91-3 Probechem Biochemicals

Chemical Structure : BI-1347

CAS No.: 2163056-91-3

加入收藏

货号: PC-63252Not For Human Use, Lab Use Only.

BI-1347 is a potent, selective inhibitor of CDK8/CDK19 with IC50 of 1.4 nM/1.9 nM, respectively.

获取报价单

or Bulk Inquiry

大包装，大折扣！

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

生物&药学活性

BI-1347 is a potent, selective inhibitor of CDK8/CDK19 with IC50 of 1.4 nM/1.9 nM, respectively.

BI-1347 displays no inhibition of other CDKs tested (e.g. CDK1, CDK2, CDK4, CDK6, CDK7 and CDK9).

BI-1347 impacts the growth of a subset of hematological cancer cells lines, whilst solid tumor cell lines are unaffected

BI-1347 potently decrease the phosphorylation of STAT1 S727.

BI-1347 enhances the NK cell cytotoxicity results in a strong synergistic antitumor efficacy in the murine syngeneic EMT6 breast cancer model.

分子量	356.429
分子式	C22H20N4O
外观性状	Solid
CAS No.
储存条件	固体粉末 -20 °C 12 个月; 4°C 6 个月	配置液 -80 °C 6 个月; -20°C 6 个月
Shipping
Solubility	10 mM in DMSO
Chemical Name/SMILES	2-(4-(4-(isoquinolin-4-yl)phenyl)-1H-pyrazol-1-yl)-N,N-dimethylacetamide

1. Hofmann MH, et al. Mol Cancer Ther. 2020 Apr;19(4):1018-1030.